SCHEMBL25321386

SCHEMBL25321386

CC(C)(C)OC(=O)N[C@H](CCCn1ccc2cc(-c3ncc(C(F)(F)F)cn3)c(F)cc2c1=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TIPARP Q7Z3E1 6/20 0.46
▸ PPARG P37231 1/20 0.38
▸ PPARA Q07869 1/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ ITGA4 P13612 2/20 0.35
▸ ITGB7 P26010 2/20 0.35
▸ CCKAR P32238 2/20 0.33
▸ CCKBR P32239 2/20 0.33
▸ HDAC4 P56524 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ MDM2 Q00987 2/20 0.33
▸ P2RX3 P56373 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ PLK1 P53350 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30550616 1.00 TIPARP (0.46) TIPARPPPARGPPARAPTPN1ITGA4
SCHEMBL25321393 1.00 TIPARP (0.46) TIPARPPPARGPPARAPTPN1ITGA4
SCHEMBL30550717 0.93 TIPARP (0.46) TIPARPPPARGPPARAPTPN1ITGA4
SCHEMBL26782305 0.93 TIPARP (0.46) TIPARPPPARGPPARAPTPN1ITGA4
SCHEMBL30550827 0.89 TIPARP (0.49) TIPARPPLK1
SCHEMBL25319270 0.89 TIPARP (0.49) TIPARPPLK1
SCHEMBL25319273 0.89 TIPARP (0.49) TIPARPPLK1
SCHEMBL30550605 0.88 TIPARP (0.50) TIPARP
SCHEMBL25320426 0.88 TIPARP (0.50) TIPARP
SCHEMBL25320428 0.88 TIPARP (0.50) TIPARP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459922-B2 PARP7 inhibitors GILEAD SCIENCES, INC. (US) 2025-11-04 — — US disclosed
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 — — US disclosed
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 — — US disclosed
WO-2023147418-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-08-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459922-B2 PARP7 inhibitors PARP1, PARP11, PARP2 TIPARP 491/4885PPARG 1967/4885PPARA 2003/4885
US-20230365529-A1 PARP7 INHIBITORS PARP1, PARP11, PARP2 TIPARP 491/4885PPARG 1967/4885PPARA 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback